Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on: June 24,2024

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on:June 24,2024

Scientists advise caution in immunotherapy research

by Yale UniversityCredit: CC0 Public DomainIn a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caut

Updated on: March 06,2024

Scientists advise caution in immunotherapy research

by Yale UniversityCredit: CC0 Public DomainIn a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caut

Updated on:March 06,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on: June 22,2024

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on:June 22,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on: February 24,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on:February 24,2024

Researchers develop alcohol intervention for women attending breast screening appointments

by Monash UniversityCredit: Unsplash/CC0 Public DomainMonash University, Turning Point and the Victorian Health Promotion Foundation (VicHealth) have developed a successful alcohol intervention f

Updated on: February 03,2024

Researchers develop alcohol intervention for women attending breast screening appointments

by Monash UniversityCredit: Unsplash/CC0 Public DomainMonash University, Turning Point and the Victorian Health Promotion Foundation (VicHealth) have developed a successful alcohol intervention f

Updated on:February 03,2024

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across

Updated on: February 18,2024

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across

Updated on:February 18,2024

Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Updated on: June 15,2024

Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Updated on:June 15,2024

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act

Updated on: March 01,2024

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act

Updated on:March 01,2024

Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified

Updated on: February 23,2024

Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified

Updated on:February 23,2024

Researchers detect a loophole in chronic lymphocytic leukemia treatment

by Rockefeller University PressThe adhesive protein CD49d (red) is present on the surface of these adherent chronic lymphocytic leukemia cells. Credit: Tissino et al., 2018A team of researchers i

Updated on: March 01,2024

Researchers detect a loophole in chronic lymphocytic leukemia treatment

by Rockefeller University PressThe adhesive protein CD49d (red) is present on the surface of these adherent chronic lymphocytic leukemia cells. Credit: Tissino et al., 2018A team of researchers i

Updated on:March 01,2024

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for

Updated on: March 30,2024

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for

Updated on:March 30,2024